MEYER HANDELMAN CO

Position in LBRX — Lb Pharmaceuticals Inc

CIK 45319 RYE BROOK, NY

Position in LBRX

as of Mar 31, 2026 · filed Apr 20, 2026 Compact

Position Value

$372,218

New position

Shares Held

15,094

first reported quarter

Ownership

0.053%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

MEYER HANDELMAN CO holds $2,771,741 across 4 Biotechnology names. LBRX ranks #2 (13.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	2,581	$1,994,183
2	LBRX	Lb Pharmaceuticals Inc This page	15,094	$372,218
3	VRTX	Vertex Pharmaceuticals Inc / Ma	575	$256,760
4	ELTX	Elicio Therapeutics, Inc.	13,899	$148,580

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$372,218	15,094	—	Shares	Sole	2026-04-20
No filing history on record for this holder in this stock.